This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
Home » Vencorex Reinforces Global Footprint with New Production Capacities
Vencorex announced the completion of industrial projects that include the expansion of monomer (HDI and IPDI) capacity in France (Pont de Claix site), a new derivatives unit (Tolonate™) at its Rayong, Thailand, plant, and a new waterborne derivatives (Easaqua™) production chain at its Freeport, Texas, site.
“Vencorex teams have been fully committed to these industrial projects and delivered on expected targets. The Sales and Marketing teams are now focusing to serve the market with capacity that follows the growth demand of our customers,” said Xavier Fournier, Vencorex CEO.